Portfolio news 0

Abliva

Abliva AB - Pharming announces public cash offer to the shareholders of Abliva AB

Oxa

DHL partners with Oxa for autonomous vehicle project at Heathrow

HORIBA MIRA partners with Monolith to enhance its battery testing through AI

Oxford Nanopore Technologies Plc

Oxford Nanopore and UK Biobank to create world's largest epigenetic dataset targeting the causes of cancer, dementia, complex disease

C-Capture Ltd

C-Capture’s technology in biofuels trial to achieve net zero

Microbiotica Ltd

Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients

Storm Therapeutics

STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024

Oxford Nanopore Technologies Plc

Oxford Nanopore announces senior leadership changes

Genomics

New study from Genomics indicates individuals who have a genetic predisposition for high BMI may require tailored approaches to tackle obesity

Oxford Nanopore Technologies Plc

New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore